Misleading Marketing Practices in Email Notice by BAT Subsidiary

Regulations by Zheng Mingwei
Sep.26.2023
Misleading Marketing Practices in Email Notice by BAT Subsidiary
BAT's subsidiary, Reynolds, is accused of engaging in unfair competition by sending misleading emails to distributors.

Previously, 2FIRSTS reported on the incident where British American Tobacco (BAT) subsidiary, Reynolds Marketing Services (which represents Reynolds American Tobacco Company), sent a "reminder email" titled "FDA Enforcement Notice on the Retail Sale of Elf Bar and Esco Bars e-cigarettes" to distributors and wholesalers. In response to this event, 2FIRSTS sought the expertise of Zheng Mingwei, the equity partner and director of the Corporate Affairs Committee at Beijing Zhongyin (Shenzhen) Law Firm. According to Mr. Zheng, the email sent by Reynolds Tobacco may be considered an exaggeration and misleading, potentially constituting unfair competition.

 

Potential Motives for Unfair Competition

 

Looking back at the "Reminder Email" incident, Reynolds Tobacco listed several Chinese e-cigarette brands, including ELFBAR, EBDesign, Kangertech, Lava, Cali, Bang, Esco Bars, Innokin, Puff Max, Hyde, Puff Bar, and Breeze, in the body of the email. Reynolds Tobacco cited a previous announcement by the FDA stating that these products are all disposable e-cigarette products that have not received pre-market tobacco product application (PMTA) approval.

 

Lawyer Zheng Mingwei pointed out that the controversial "reminder email" from Reynolds primarily involves its competitive relationships with rivals ELFBAR and EB Design. After conducting a fact check on the incident, lawyer Zheng Mingwei believes that Reynolds's email has an overly broad scope in its subject line (the warning letter only targets specific products, not the entire brand, whereas Reynolds's headline exaggerates it as "Notice of FDA Enforcement Against Retailers for Selling Elf Bar and Esco Bars E-Cigarettes"), thereby magnifying the range of products that ELFBAR and EB Design were warned about. Reynolds Tobacco's communication has the potential to mislead readers and may indicate a possibility of engaging in unfair competition tactics against its peers by exaggerating and misleading information.

 

He emphasized that on one hand, Reynolds Tobacco pointed out that brands such as ELFBAR and EB Design do not have licenses, while on the other hand, they are promoting their own unauthorized product (Vuse Alto), which could "suggest" that their product is legal and has passed the PMTA review. This could be misleading to wholesalers, retailers, consumers, etc. and potentially serve the purpose of unfair competition.

 

However, he also pointed out that the other comments in the email are all direct quotations from official FDA press releases, and no false information was found.

 

According to lawyer Zheng Mingwei's comprehensive analysis, although the email contents from Reynolds Tobacco involve exaggerated and misleading practices of unfair competition, the overall context is not remarkable. However, if they persist in the misconduct after receiving a warning letter, the malicious intent becomes more apparent.

 

Damage Business Reputation of Competitors

 

Lawyer Zheng Mingwei also commented on the legal impact of the "warning email" at the legal level. This incident involves both the federal level of the United States' laws against unfair competition and state-level laws. Zheng pointed out that the actions of Reynolds Tobacco may constitute false advertising under the Lanham Act, Section 43(a), which prohibits the use of false or misleading statements in advertising.

 

He emphasized that the majority of the Anti-Unfair Competition Law belongs to the state level in the United States. In this case, the actions of Reynolds Tobacco may constitute trade libel, similar to Article 11 of China's Anti-Unfair Competition Law. According to the jurisdiction of American law, it refers to the defendant's place of residence or the location with the minimum contact with the defendant's actions.

 

In terms of Chinese law, Reynolds Tobacco may potentially be implicated under Article 8 of the Anti-Unfair Competition Law, as well as Article 17 of the Interpretation of the Anti-Unfair Competition Law: misleading commercial advertising. Furthermore, Article 11 of the Anti-Unfair Competition Law states that operators are prohibited from fabricating or disseminating false or misleading information, which could harm the business reputation and product reputation of competitors.

 

Lawyer Zheng Mingwei stated that according to Article 27 of the Interpretation of the Anti-Unfair Competition Law, if the alleged unfair competition behavior occurs outside the territory of the People's Republic of China (PRC), but the infringement results occur within the territory of the PRC, the party claiming jurisdiction by the court where the infringement occurred should be supported by the people's court.

 

However, there is considerable controversy over whether jurisdiction can be obtained domestically. Some viewpoints believe that, based on the "two-convenience" principle ("convenient for the litigants and convenient for the people's courts to exercise their judicial power independently, fairly, and efficiently"), Reynolds Tobacco's actions in this case could potentially be considered as infringement occurring within Chinese territory and therefore fall under the jurisdiction of Chinese courts.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.